I guess you can see the difference between the 2
[DOI] [PMC free article] [PubMed] [Google Scholar] 6.Steullet P., Cabungcal J.H., Monin A., Dwir D., ODonnell P., Cuenod M., Do K.Q
Metabolic Biomarkers: Utilized in controlled models measuring endocrine-linked metabolic readouts alongside pathway markers
Investigated applications In the published preclinical and clinical literature, the effects of NAD+ (and its precursors) are documented in the following areas: Age-related decline of functions , robustly demonstrated in animal models Mitochondrial dysfunctions , emerging clinical data Neurodegenerative diseases (Alzheimers, Parkinsons), Phase 2 trials Chronic fatigue syndrome , observational data, IV NAD+ therapy Addiction treatment , alcohol, opioids (anecdotal, some studies) Metabolic syndrome and insulin resistance , Phase 2 data with NMN Cardiovascular function , endothelial function, blood pressure Skin aging , cosmetic research Post-COVID long-term symptoms , emerging research Sarcopenia , preclinical and Phase 2 data Buying NAD+: what to look for When buying NAD+ , the decisive criterion is not the price but the verifiability of quality
It is better to take a bioavailable, moderate dose that your body can actually use
